Pharmaceutical Technology on MSN
Aktis Oncology kicks 2026 IPO cycle off with $210m target
"Aktis Oncology kicks 2026 IPO cycle off with $210m target" was originally created and published by Pharmaceutical Technology ...
Sound Point Meridian Capital Inc. remains a Buy despite a -35% price drop and -23% total return since December 2024. Click ...
As 2025 draws to a close, the cryptocurrency market remains complicated, leading to a notable increase in investor caution. Consequently, presale projects are u ...
India’s initial public offering (IPO) market has moved beyond cyclical swings and is now structurally driven by domestic ...
Navan is a relatively new IPO that is successfully disrupting the travel booking and management space. Learn more about NAVN ...
Livewire Markets on MSNOpinion
The Bitcoin (and crypto) outlook for 2026
But as 2026 gets up and running, the outlook for Bitcoin and crypto is much harder to pin down. Despite reaching a record ...
Executive chairman and managing director Steven Tan intends to capitalise on the construction tailwinds through a selective, results-focused growth strategy for Attika Group.
Nvidia is spending its market valuation windfall not on random diversification but on buying the knobs and levers that decide ...
Debt and equity capital markets saw vigorous engagement in 2025 as issuers and borrowers stepped up their fundraising forays to finance business growth plans. As the US rates cycle turned last year, ...
The HBO thriller Industry thrives thanks to its cunning characters, like Myha'la's Harper and Marisa Abela's Yasmin, but who ...
Australia’s beef and wheat exports are world class but our stock exchange is a ghost town for agriculture. Could the giants ...
Private markets are resetting. Valuations have adjusted, dispersion is rising, and selective opportunities are starting to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results